Data Insights
Artificial Intelligence (7)
Big Data (5)
Biosimilars (1)
Blockchain (2)
Cell & Gene Therapy (1)
Cloud (4)
Corporate Governance (3)
Covid-19 (4)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (5)
Future of Work (3)
Genomics (1)
Health & Wellness (1)
Immuno-oncology (7)
Internet of Things (3)
Microbiome (2)
Mobile Health (1)
Nanomedicine (1)
Oncology (3)
Orphan Designated Drugs (7)
Other Innovation Areas (8)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (1)
Smart Hospitals (3)
Social Responsibility (6)
Virtual Care (3)
Showing 4 results out of 4
How did the pharmaceutical industry treat cybersecurity in Q4 2023 filings?
The global pharmaceutical industry experienced a 15% drop in company filings mentions of cybersecurity in Q4 2023 compared with the...
Q4 2023 update: cybersecurity related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that cybersecurity accounted for 2 pharmaceutical deals announced in Q4 2023,...
Q3 2023 update: cybersecurity related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 37% drop in new job postings related to cybersecurity in Q3 2023 compared with...
Q3 2023 update: mentions of cybersecurity in pharmaceutical industry filings
The global pharmaceutical industry experienced a 16% drop in company filings mentions of cybersecurity in Q3 2023 compared with the...